Pierce Christopher
Insider CIK 1824631 · PRLD EVP and Chief of Business Oper
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2021-09-02 | 2021-09-07 | 17,000 | — | $0 | 207,796 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-09-02 | 2021-09-07 | 6,930 | $42.50 | $294.5K | 3,750 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2021-09-02 | 2021-09-07 | 17,000 | $12.85 | $218.4K | 20,750 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-09-02 | 2021-09-07 | 3,343 | $40.29 | $134.7K | 17,407 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-09-02 | 2021-09-07 | 6,727 | $41.52 | $279.3K | 10,680 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2021-07-20 | 2021-07-22 | 85,000 | — | $0 | 85,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2021-04-29 | 2021-04-30 | 3,295 | — | $0 | 4,323 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-04-29 | 2021-04-30 | 3,295 | $40.29 | $132.8K | 3,750 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise | 2021-04-29 | 2021-04-30 | 3,295 | $1.89 | $6.2K | 7,045 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2021-04-08 | 2021-04-15 | 200 | — | $0 | 7,618 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-04-08 | 2021-04-15 | 200 | $40.00 | $8.0K | 3,750 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award | 2021-04-08 | 2021-04-15 | 200 | $1.89 | $378 | 3,950 | SEC↗ |
| PRLD Prelude Therapeutics Inc | M Exercise deriv | 2021-04-07 | 2021-04-09 | 828 | — | $0 | 7,818 | SEC↗ |
| PRLD Prelude Therapeutics Inc | S Sale | 2021-04-07 | 2021-04-09 | 828 | $40.08 | $33.2K | 3,750 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award | 2021-04-07 | 2021-04-09 | 828 | $1.89 | $1.6K | 4,578 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2020-09-29 | 2020-09-29 | 3,750 | $19.00 | $71.3K | 3,750 | SEC↗ |